Older people experience a disproportionate number of medicine-related adverse events. GPs, often the first point of contact for most people aged 65 years and over, are best placed to review and rationalise medicine use for their patients.
RACGP 40 (Category 1) QI&CPD points (QI activity)Toggle information
This activity has been accredited for 40 (Category 1) points (QI activity) in the RACGP QI&CPD Program for the 2017–2019 triennium (activity ID number 92159).
ACRRM 30 PRPD pointsToggle information
This activity has been accredited for 30 PRPD points in the ACRRM PDP Program for the 2017–2019 triennium (code 7359).
- Recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI)
Older people experience a disproportionate number of medicine-related adverse events. GPs are often the first point of contact for most people aged 65 years and over, therefore GPs are best placed to review and rationalise medicine use for their patients.
Reflect on your management of 10 patients aged ≥ 75 years old using 5 or more medicines and prescribed at least one of the following:
- an antipsychotic medicine for behavioural and psychological symptoms of dementia OR
- a benzodiazepine for insomnia OR
- an opioid for chronic non-cancer pain
Our Clinical e-Audits are free quality improvement activities that help GPs review their current prescribing practice for patients with certain conditions, compared with current best practice guidelines.
- completing electronic data collection for 10 patients
- securely submitting de-identified data online
-receiving immediate patient
- specific feedback to assist implementation of changes to practice
- reviewing individual and peer feedback results based on best practice clinical indicators
- recording progress of individual patients automatically identified for review
- reflecting on improvements in practice.
Participation in this activity will assist GPs to:
- implement a systematic approach to review older people's medicines as recommended in current guidelines, in particular considering indication and adverse events
- assess for risk factors in older people that may contribute to medicines-related problems
- discuss the benefits of non-pharmacological therapies for your older patient
- evaluate response to medicines and assess the need for ongoing therapy specifically for antipsychotic medicines, benzodiazepines and opioids.
You will have access to:
- up-to-date clinical guidance: this activity will provide evidence-based information to update your knowledge and practical advice to provide to your patients.
- expert commentary: an expert commentary will become available when at least 100 GPs have submitted their Initial data. The expert commentary will be provided by Professor David Le Couteur (Geriatric Medicine, Concord Clinical School, ANZAC Research Institute).